Keeping Current

The Evolution of Antibody-Drug Conjugate Therapy for Gastric/GEJ Cancers: Latest Data and Clinical Implications

Informações:

Synopsis

Could the latest data in novel antibody-drug conjugates reshape your treatment approach for patients with gastric cancer?   Credit available for this activity expires: 7/1/2026 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002638?ecd=bdc_podcast_libsyn_mscpedu